- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07938112
Efficacy and Safety of Electroacupuncture in the Treatment of Esophageal Symptoms in Non-erosive Reflux Disease (NERD) Patients
Investigating the Efficacy and Safety of Electroacupuncture in the Treatment of Esophageal Symptoms in Non-erosive Reflux Disease (NERD) Patients: A Pilot, Randomized Double-blinded, Sham-controlled Trial
The goal of this clinical trial is to learn if acupuncture works to treat non-erosive reflux disease (NERD) patients. The main questions it aims to answer are:
- Electroacupuncture (EA) is superior to sham EA in terms of easing the symptom severity of NERD.
- Acupuncture is able to influence gastrointestinal function, autonomic regulation, and stress responses in NERD patients.
Participants will:
- Receive acupuncture treatment twice per week for 6 weeks.
- Leave plasma, serum, saliva, stool, and urine samples at baseline, mid-treatment, and end-of-treatment.
- Complete patient-reported-outcomes (PROs) at baseline, mid-treatment, and end-of-treatment
연구 개요
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Linda LD Zhong, PhD
- 전화번호: +65 67911744
- 이메일: linda.zhong@ntu.edu.sg
연구 연락처 백업
- 이름: Huangyan Chen
- 전화번호: +65 97663672
- 이메일: huangyan001@e.ntu.edu.sg
연구 장소
-
-
-
Singapore, 싱가포르, S637551
- Nanyang Technological University, School of Biological Sciences
-
연락하다:
- Huangyan Chen
- 전화번호: +65 97663672
- 이메일: huangyan001@e.ntu.edu.sg
-
연락하다:
- Linda LD Zhong, PhD
- 전화번호: +65 65921733
- 이메일: linda.zhong@ntu.edu.sg
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Adults aged 21 to 75 years at the time of consent;
- Presence of heartburn, regurgitation or chest pain before screening with a frequency of at least twice a week;
- No evidence of esophageal mucosal injury on endoscopy within the past 5 years;
- GERD-Q score ≥8 (indicating active GERD symptoms);
- Ability and willingness to provide written informed consent to participate.
Exclusion Criteria:
-
Structural or organic gastrointestinal disease, including but not limited to:
- gastrointestinal malignancy,
- eosinophilic esophagitis,
- esophageal stricture, varices, or infections,
- active peptic ulcer disease,
- gastric or duodenal tumors;
-
Presence of alarming symptoms (e.g. severe dysphagia, hematemesis, unexplained weight loss, or hematochezia, etc.);
-
History of digestive tract surgery or esophageal interventions, including chemotherapy, radiotherapy, radiofrequency ablation, endoscopic mucosal resection, or cryotherapy;
-
Use of prohibited medical treatment:
- acupuncture treatment on the abdomen and chest within past 1 month,
- concomitant medication affecting gastrointestinal motility or visceral sensitivity (antidiarrheals, antidepressants, narcotic analgesics, anticholinergics, etc.),
- antibiotics, prebiotics, probiotics, or immunosuppressants within 1 month prior to screening;
-
Presence of an implanted cardiac pacemaker;
-
History of hypersensitivity to acupuncture, or needle phobia;
-
Severe psychiatric illness (e.g. schizophrenia, major depression, dementia), cognitive impairment, or other conditions likely to compromise adherence to study procedures;
-
Pregnant or breastfeeding;
-
Current participation in other clinical trials that could interfere with study outcomes.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Electroacupuncture (EA)
The WHO Standardized Acupuncture Points Location will be used to identify the location of these acupoints: ST36 Zusanli, PC6 Neiguan, CV12 Zhongwan, LR3 Taichong, SP4 Gongsun; and auxiliary acupoints added according to symptom severity: PC7 Daling, ST44 Neiting, EX-HN3 Yintang, ST37 Shangjuxu, SP6 Sanyinjiao, LU7 Lieque. After sterilizing the skin, needles of 0.25 mm in diameter and 25-40 mm in length will be inserted into the acupoints to a depth of 10-30 mm outward and upward slightly. Needles will be lifted, thrust, and twirled evenly 3 times to achieve "de-qi". Paired electrodes of the EA apparatus will be attached transversely to the acupoint respectively with a continuous wave of 2/100 Hz and a current intensity of 1-5 mA (preferably with the skin around the acupoints shivering mildly without pain) for 30 min. |
The acupuncture needles and related equipment will have already received approval for routine Traditional Chinese Medicine (TCM) clinical practice in Singapore. |
|
가짜 비교기: Sham-electroacupuncture (SEA)
The sham electroacupuncture group (SEA) penetrates acupuncture on non-acupuncture points (1 B-cun away from the acupuncture point and meridian). The same type of acupuncture needles will be used for SEA with the exact skin sterilization method. Insertion depth will be approximately less than 10 mm. The electrostimulator will not be switched on for these patients. All needles will be removed after 30 min of needle retention. |
The acupuncture needles and related equipment will have already received approval for routine Traditional Chinese Medicine (TCM) clinical practice in Singapore. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Gastroesophageal Reflux Disease Questionnaire (GERDQ)
기간: From enrollment to the end of follow-up at 16 weeks
|
≥ 50% reduction in total GERD-Q score or normalization (<8) |
From enrollment to the end of follow-up at 16 weeks
|
|
Gastrointestinal Symptom Rating scale (GSRS)
기간: From enrollment to the end of follow-up at 16 weeks
|
≥ 0.5 point decrease in mean GSRS Reflux domain value |
From enrollment to the end of follow-up at 16 weeks
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Quality of Life in Reflux and Dyspepsia questionnaire (QOLRAD)
기간: From enrollment to the end of follow-up at 16 weeks
|
≥ 0.5 point improvement on the mean QOLRAD score |
From enrollment to the end of follow-up at 16 weeks
|
|
Euro QoL (EQ-5D-5L)
기간: From enrollment to the end of follow-up at 16 weeks
|
change in index utility |
From enrollment to the end of follow-up at 16 weeks
|
|
Hospital Anxiety and Depression Scale (HADS)
기간: From enrollment to the end of follow-up at 16 weeks
|
categorical shift from ≥ 11 to < 11 or ≥ 8 to < 8, or ≥ 1.5 point reduction per HADS-A and HADS-D subscale |
From enrollment to the end of follow-up at 16 weeks
|
|
Visceral Sensitivity Index (VSI)
기간: From enrollment to the end of follow-up at 16 weeks
|
≥ 15% reduction from baseline |
From enrollment to the end of follow-up at 16 weeks
|
|
Esophageal Hypervigilance and Anxiety Scale (EHAS) Short Form
기간: From enrollment to the end of follow-up at 16 weeks
|
≥ 15% reduction from baseline |
From enrollment to the end of follow-up at 16 weeks
|
|
Simplified Constitution of Chinese Medicine Questionnaire (CCMQ)
기간: At baseline
|
At baseline
|
|
|
Traditional Chinese medicine functional gastrointestinal disorders syndrome scale (TCM-FGID)
기간: From enrollment to the end of follow-up at 16 weeks
|
(Total syndrome score before treatment - Total syndrome score after treatment) / Total syndrome score before treatment × 100% |
From enrollment to the end of follow-up at 16 weeks
|
|
Bang's blinding index (BBI)
기간: End of first week and sixth week of intervention
|
End of first week and sixth week of intervention
|
|
|
James' blinding index (JBI)
기간: End of first week and sixth week of intervention
|
End of first week and sixth week of intervention
|
|
|
Patient's global impression of change (PGIC)
기간: From mid-treatment to the end of follow-up at 16 week
|
From mid-treatment to the end of follow-up at 16 week
|
|
|
Daily patient diary
기간: From enrollment to the end of follow-up at 16 weeks
|
From enrollment to the end of follow-up at 16 weeks
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Linda LD Zhong, PhD, Nanyang Technological University
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD sharing will be available upon request.
IPD 공유 기간
Data will become available within 7 years after completion of the clinical trial.
IPD 공유 액세스 기준
Individual participant data (IPD) will be made available to qualified researchers upon request. To access the data, researchers must submit a formal request, which will be reviewed and approved by the data-sharing committee. Data access will be granted for research purposes only and will require adherence to data use agreements and ethics guidelines.
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
- ICF
- ANALYTIC_CODE
- CSR
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .